genedrive (LON:GDR) Issues Earnings Results

genedrive (LON:GDRGet Free Report) posted its quarterly earnings data on Monday. The company reported GBX (0.90) EPS for the quarter, Digital Look Earnings reports. genedrive had a negative net margin of 1,412.18% and a negative return on equity of 191.22%.

genedrive Stock Performance

GDR stock opened at GBX 1.15 on Monday. The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35. The firm has a market cap of £11.81 million, a PE ratio of -1.27 and a beta of -0.04. The business has a 50 day moving average of GBX 0.97 and a 200-day moving average of GBX 0.80. genedrive has a 12-month low of GBX 0.19 and a 12-month high of GBX 2.20.

About genedrive

(Get Free Report)

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.

Featured Articles

Earnings History for genedrive (LON:GDR)

Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.